CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases 2019

Biocon  /  News – Posts  /  Press Releases  /  Press Releases 2019

Biocon & Equillium Expand Exclusive Licensing Agreement for Itolizumab to Include Australia and New Zealand
  • Thu, 12-Dec-2019
  • Posted by: BIOCON
No Comments

Biocon Biologics Symposium on ‘100 years of Insulin – Delivering on Universal Access & Equitable Care’ Resonates Well with Leading KOLs at IDF Congress 2019
  • Wed, 11-Dec-2019
  • Posted by: BIOCON
No Comments

Biocon Biologics Takes Forward Its Mission to Unlock Universal Access to Insulins Globally
  • Tue, 03-Dec-2019
  • Posted by: BIOCON
No Comments

Siddharth Mittal Takes Over as CEO and Joint Managing Director of Biocon Limited
  • Tue, 03-Dec-2019
  • Posted by: BIOCON
No Comments

Biocon and Mylan Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.
  • Mon, 02-Dec-2019
  • Posted by: BIOCON
No Comments

USFDA Approves Biocon’s sBLA for Pegfilgrastim New Manufacturing Facility
  • Wed, 27-Nov-2019
  • Posted by: BIOCON
No Comments

Kiran Mazumdar-Shaw Conferred with Lifetime Achievement Award by Indian Council of Medical Research
  • Mon, 18-Nov-2019
  • Posted by: BIOCON
No Comments

Biocon Features in the Prestigious ASIA IP ELITE List for the Fourth Consecutive Year
  • Tue, 12-Nov-2019
  • Posted by: BIOCON
No Comments

Biocon’s Biologics Drug Products Facility in Bengaluru Receives EIR from U.S. FDA
  • Tue, 05-Nov-2019
  • Posted by: BIOCON
No Comments

Biocon Moves Up to Rank No. 6 on Science Careers’ Top 20 Global Pharma & Biotech Employers List 2019
  • Mon, 28-Oct-2019
  • Posted by: BIOCON
No Comments
Report adverse event/ side effects and/or product complaints for Biocon products.

* Safe Harbour | Privacy Policy | Terms of Use © 2022, Biocon. All Rights Reserved
Share
Previous Next
Close
Test Caption
Test Description goes like this